Targeted radiation blitz aims to outsmart deadly brain cancer

NCT ID NCT04574856

Summary

This study is testing a new, more precise way to deliver radiation therapy to people newly diagnosed with glioblastoma, a fast-growing brain tumor. Doctors will use advanced MRI scans during treatment to target higher radiation doses specifically to the most resistant parts of the tumor, while patients also receive standard chemotherapy. The main goal is to see if this intensified, adaptive approach helps patients live longer than the current standard treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of Michigan Rogel Cancer Center

    Ann Arbor, Michigan, 48109, United States

Conditions

Explore the condition pages connected to this study.